Author: sickle cell news

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for treatment of SCD

Modus Therapeutics AB, a company developing innovative treatments in disease areas with high unmet medical need with a focus on sickle cell disease (SCD), announces that the FDA has accepted its sevuparin IND for the treatment of SCD. “The FDA’s decision to accept the IND application for the development of sevuparin in sickle cell disease…

the exchange blood transfusion that nearly went wrong

<script async src=”//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js”></script> <script> (adsbygoogle = window.adsbygoogle || []).push({ google_ad_client: “ca-pub-2518713246101055”, enable_page_level_ads: true }); </script>   Mother of twins, Mariam Kay, and Founder, Dora Foundation, UK often got admitted thrice to the emergency room in one week; now she recalls the exchange blood transfusion that nearly went wrong.